NCT00273182

Brief Summary

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three or four leads (soft insulated wires) that are inserted through the veins to the heart. The purpose of this study is to monitor the long-term performance of the InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) systems for cardiac resynchronization therapy (CRT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,999

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2002

Longer than P75 for all trials

Geographic Reach
1 country

82 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2002

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 9, 2006

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

August 5, 2013

Completed
Last Updated

August 5, 2013

Status Verified

July 1, 2013

Enrollment Period

9.1 years

First QC Date

January 4, 2006

Results QC Date

April 13, 2012

Last Update Submit

July 1, 2013

Conditions

Keywords

Heart FailureCardiomyopathyCardiac pacingCardiac resynchronization therapy

Outcome Measures

Primary Outcomes (1)

  • Overall Death Rate and Cause Specific Death Rate During Three Years Post Implant.

    Survival curves of overall mortality and cause specific mortality (due to progressive heart failure and sudden cardiac death) were created based on Kaplan-Meier estimates. Estimates went out to 36 month time point. Confidence intervals were calculated on a log-log scale. The Kaplan-Meier estimates are reported in the statistical analysis modules

    36 month follow-up

Secondary Outcomes (4)

  • Left Ventricular (LV) Lead R-wave Amplitude

    36 month follow-up

  • Left Ventricular (LV) Lead Impedance

    36 months follow-up

  • Left Ventricular (LV) Lead Pacing Voltage Threshold

    36 months follow-up

  • Subjects With Left Ventricular (LV) Lead Related Complications During Three Years Post-implant

    36 months follow-up

Study Arms (1)

Cohort

Patients implanted with InSync Model 8040, InSync III Model 8042 , or Medtronic CRT-D system. A total of 1999 subjects were enrolled in the study. Of them, 1738 had successful post market implants of InSync Model 8040 (601 subjects), InSync III Model 8042 (512 subjects) and CRT-D devices (625 subjects). The rest 262 subjects came from two pre-market studies: the MIRACLE study added 141 subjects to InSync Model 8040, and the InSync III study added 121 subjects to the InSync III Model 8042. A total of 1014 subjects completed the study through 36 month follow up. Follow-up of 1000 subjects was required by the FDA to satisfy the conditions of approval.

Device: InSync Model 8040Device: InSync III Model 8042

Interventions

Subjects with sucessful implants of InSync Model 8040.

Cohort

Subjects with successful implants of InSync III Model 8042

Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients indicated for use of a cardiac device

You may qualify if:

  • Patients implanted with an InSync Model 8040 or InSync III Model 8042, a right ventricular lead, and a Medtronic market-released left ventricular lead as part of a system to deliver cardiac resynchronization therapy.

You may not qualify if:

  • Patients with a history of a previously failed placement of a currently investigational Medtronic left ventricular lead within 30 days of enrollment in the InSync Registry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (82)

Unknown Facility

Birmingham, Alabama, United States

Location

Unknown Facility

Peoria, Arizona, United States

Location

Unknown Facility

Fort Smith, Arkansas, United States

Location

Unknown Facility

Little Rock, Arkansas, United States

Location

Unknown Facility

Long Beach, California, United States

Location

Unknown Facility

Napa, California, United States

Location

Unknown Facility

Oxnard, California, United States

Location

Unknown Facility

San Diego, California, United States

Location

Unknown Facility

Yuba City, California, United States

Location

Unknown Facility

Washington D.C., District of Columbia, United States

Location

Unknown Facility

Gainesville, Florida, United States

Location

Unknown Facility

Jacksonville, Florida, United States

Location

Unknown Facility

Jupiter, Florida, United States

Location

Unknown Facility

Melbourne, Florida, United States

Location

Unknown Facility

Miami, Florida, United States

Location

Unknown Facility

Orlando, Florida, United States

Location

Unknown Facility

Tampa, Florida, United States

Location

Unknown Facility

Atlanta, Georgia, United States

Location

Unknown Facility

Rockford, Illinois, United States

Location

Unknown Facility

Springfield, Illinois, United States

Location

Unknown Facility

Indianapolis, Indiana, United States

Location

Unknown Facility

Des Moines, Iowa, United States

Location

Unknown Facility

Kansas City, Kansas, United States

Location

Unknown Facility

Overland Park, Kansas, United States

Location

Unknown Facility

Lexington, Kentucky, United States

Location

Unknown Facility

Louisville, Kentucky, United States

Location

Unknown Facility

Lake Charles, Louisiana, United States

Location

Unknown Facility

Shreveport, Louisiana, United States

Location

Unknown Facility

Baltimore, Maryland, United States

Location

Unknown Facility

Salisbury, Maryland, United States

Location

Unknown Facility

Silver Spring, Maryland, United States

Location

Unknown Facility

Boston, Massachusetts, United States

Location

Unknown Facility

Worchester, Massachusetts, United States

Location

Unknown Facility

Detroit, Michigan, United States

Location

Unknown Facility

Kalamazoo, Michigan, United States

Location

Unknown Facility

Lansing, Michigan, United States

Location

Unknown Facility

Marquette, Michigan, United States

Location

Unknown Facility

Saginaw, Michigan, United States

Location

Unknown Facility

Duluth, Minnesota, United States

Location

Unknown Facility

Minneapolis, Minnesota, United States

Location

Unknown Facility

Hattiesburg, Mississippi, United States

Location

Unknown Facility

Tupelo, Mississippi, United States

Location

Unknown Facility

Columbia, Missouri, United States

Location

Unknown Facility

Kansas City, Missouri, United States

Location

Unknown Facility

Saint Joseph, Missouri, United States

Location

Unknown Facility

Springfield, Missouri, United States

Location

Unknown Facility

St Louis, Missouri, United States

Location

Unknown Facility

Billings, Montana, United States

Location

Unknown Facility

Lincoln, Nebraska, United States

Location

Unknown Facility

Newark, New Jersey, United States

Location

Unknown Facility

Manhasset, New York, United States

Location

Unknown Facility

New York, New York, United States

Location

Unknown Facility

Rochester, New York, United States

Location

Unknown Facility

Chapel Hill, North Carolina, United States

Location

Unknown Facility

Charlotte, North Carolina, United States

Location

Unknown Facility

High Pointe, North Carolina, United States

Location

Unknown Facility

Raleigh, North Carolina, United States

Location

Unknown Facility

Winston-Salem, North Carolina, United States

Location

Unknown Facility

Cincinnati, Ohio, United States

Location

Unknown Facility

Cleveland, Ohio, United States

Location

Unknown Facility

Columbus, Ohio, United States

Location

Unknown Facility

Mayfield Heights, Ohio, United States

Location

Unknown Facility

Oklahoma City, Oklahoma, United States

Location

Unknown Facility

Doylestown, Pennsylvania, United States

Location

Unknown Facility

Erie, Pennsylvania, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, United States

Location

Unknown Facility

York, Pennsylvania, United States

Location

Unknown Facility

Providence, Rhode Island, United States

Location

Unknown Facility

Greenville, South Carolina, United States

Location

Unknown Facility

Spartanburg, South Carolina, United States

Location

Unknown Facility

Nashville, Tennessee, United States

Location

Unknown Facility

Dallas, Texas, United States

Location

Unknown Facility

Fort Worth, Texas, United States

Location

Unknown Facility

Houston, Texas, United States

Location

Unknown Facility

Lubbock, Texas, United States

Location

Unknown Facility

Sherman, Texas, United States

Location

Unknown Facility

Salt Lake City, Utah, United States

Location

Unknown Facility

Richmond, Virginia, United States

Location

Unknown Facility

Virginia Beach, Virginia, United States

Location

Unknown Facility

Seattle, Washington, United States

Location

Unknown Facility

Morgantown, West Virginia, United States

Location

Unknown Facility

Milwaukee, Wisconsin, United States

Location

Related Publications (1)

  • Johnson WB, Abraham WT, Young JB, Wheelan K, Smith AL, Chang Y, Brinkman P; InSync Registry Investigators. Long-term performance of the attain model 4193 left ventricular lead. Pacing Clin Electrophysiol. 2009 Sep;32(9):1111-6. doi: 10.1111/j.1540-8159.2009.02451.x.

MeSH Terms

Conditions

Heart FailureCardiomyopathies

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Results Point of Contact

Title
InSync Registry Clinical Trial Leader
Organization
Medtronic, Inc.

Study Officials

  • InSync Registry Study Leader

    Medtronic

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2006

First Posted

January 9, 2006

Study Start

March 1, 2002

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

August 5, 2013

Results First Posted

August 5, 2013

Record last verified: 2013-07

Locations